Crexmed Behavioral

Menu
Call Us
Menu
Call Us
Schedule Appointment
Menu
  • Call Us
    (602) 575-5147
Menu
Call Us

Spravato

Spravato Treatment in Chandler, AZ

At Crexmed Behavioral, I understand that finding the right treatment for depression can be challenging—especially when traditional antidepressants don’t bring the relief you need. That’s why I offer Spravato® (esketamine) nasal spray, a breakthrough treatment designed for individuals struggling with treatment-resistant depression. Located conveniently on Arizona Avenue and Ray Road in Chandler, AZ, Crexmed provides a safe and supportive environment where you can begin your journey toward improved mental well-being.
Spravato is an FDA-approved nasal spray used alongside an oral antidepressant to help adults with treatment-resistant depression. Unlike traditional medications, Spravato® targets different brain pathways involved in mood regulation, helping restore balance and relieve persistent symptoms of depression. Many patients report experiencing noticeable improvement within hours to days of their first sessions, making it a powerful option for those who haven’t found success with standard antidepressants.
Spravato (esketamine) works by targeting the NMDA receptor, a key player in how the brain communicates and processes emotions. This unique mechanism helps form new connections in brain areas responsible for mood and emotional response—leading to better regulation and greater resilience.
Spravato may be an effective treatment if: You’ve tried two or more antidepressants without adequate relief You continue to experience depressive symptoms that affect daily life You’re seeking a new, clinically proven approach to mental health treatment At Crexmed Behavioral, I take the time to understand your unique situation and create a treatment plan tailored to your needs.

Spravato (esketamine) is administered as a nasal spray and is typically used in combination with an oral antidepressant medication. The treatment process for Spravato typically involves the following steps:

  1. Screening and evaluation: Before starting Spravato treatment, individuals undergo a comprehensive evaluation by a qualified healthcare provider to assess their suitability for the medication. This evaluation may include a review of medical history, a physical examination, and a mental health assessment.

  2. Prescription and dosing: If deemed appropriate, a healthcare provider will prescribe Spravato along with an oral antidepressant medication. The initial dosing and frequency of Spravato administration are determined based on the individual’s specific needs and response to treatment.

  3. Administration: Spravato is self-administered as a nasal spray under the supervision of a healthcare provider in a certified treatment center. Individuals typically receive the medication in the healthcare setting and are monitored for a period of time after administration to monitor for any adverse reactions.

  4. Ongoing monitoring and adjustments: Throughout the course of treatment, individuals are closely monitored by their healthcare provider to assess their response to Spravato and any potential side effects. Dosage adjustments or changes to the treatment plan may be made based on the individual’s progress and tolerability.

  5. Maintenance therapy: For many individuals, Spravato treatment is part of a broader maintenance therapy plan aimed at managing symptoms of depression over the long term. This may involve continued use of Spravato along with other medications and therapeutic interventions.

It’s important for individuals undergoing Spravato treatment to actively participate in their treatment plan, attend regular follow-up appointments, and communicate openly with their healthcare provider about any concerns or changes in symptoms. Additionally, adherence to the prescribed dosing schedule and safety guidelines is essential for optimizing the effectiveness and safety of Spravato treatment.

Book An Appointment